1887

Abstract

Hepatitis C virus (HCV) establishes a persistent infection that in many cases leads to cirrhosis and hepatocellular carcinoma. The non-structural 5A protein (NS5A) has been implicated in this process as it contains a C-terminal polyproline motif (termed P2) that binds to Src homology 3 (SH3) domains to regulate cellular signalling and trafficking pathways. We have shown previously that NS5A impaired epidermal growth factor (EGF) receptor (EGFR) endocytosis, thereby inhibiting EGF-stimulated EGFR degradation by a mechanism that remained unclear. As EGFR has been implicated in HCV cell entry and trafficking of the receptor involves several SH3-domain containing proteins, we investigated in more detail the mechanisms by which NS5A perturbs EGFR trafficking. We demonstrated that the P2 motif was required for the NS5A-mediated disruption to EGFR trafficking. We further demonstrated that the P2 motif was required for an interaction between NS5A and CMS, a homologue of CIN85 that has previously been implicated in EGFR endocytosis. We provided evidence that CMS was involved in the NS5A-mediated perturbation of EGFR trafficking. We also showed that NS5A effected a loss of EGFR ubiquitination in a P2-motif-dependent fashion. These data provide clues to the mechanism by which NS5A regulates the trafficking of a key cellular receptor and demonstrate for the first time the ability of NS5A to regulate host cell ubiquitination pathways.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.000145
2015-08-01
2020-09-26
Loading full text...

Full text loading...

/deliver/fulltext/jgv/96/8/2133.html?itemId=/content/journal/jgv/10.1099/vir.0.000145&mimeType=html&fmt=ahah

References

  1. Amako Y., Igloi Z., Mankouri J., Kazlauskas A., Saksela K., Dallas M., Peers C., Harris M. 2013; Hepatitis C virus NS5A inhibits mixed lineage kinase 3 to block apoptosis. J Biol Chem 288:24753–24763 [CrossRef][PubMed]
    [Google Scholar]
  2. Appel N., Zayas M., Miller S., Krijnse-Locker J., Schaller T., Friebe P., Kallis S., Engel U., Bartenschlager R. 2008; Essential role of domain III of nonstructural protein 5A for hepatitis C virus infectious particle assembly. PLoS Pathog 4:e1000035 [CrossRef][PubMed]
    [Google Scholar]
  3. Berasain C., Perugorria M.J., Latasa M.U., Castillo J., Goñi S., Santamaría M., Prieto J., Avila M.A. 2009; The epidermal growth factor receptor: a link between inflammation and liver cancer. Exp Biol Med (Maywood) 234:713–725 [CrossRef][PubMed]
    [Google Scholar]
  4. Diao J., Pantua H., Ngu H., Komuves L., Diehl L., Schaefer G., Kapadia S.B. 2012; Hepatitis C virus induces epidermal growth factor receptor activation via CD81 binding for viral internalization and entry. J Virol 86:10935–10949 [CrossRef][PubMed]
    [Google Scholar]
  5. Dikic I. 2002; CIN85/CMS family of adaptor molecules. FEBS Lett 529:110–115 [CrossRef][PubMed]
    [Google Scholar]
  6. Eden E.R., Huang F., Sorkin A., Futter C.E. 2012; The role of EGF receptor ubiquitination in regulating its intracellular traffic. Traffic 13:329–337 [CrossRef][PubMed]
    [Google Scholar]
  7. Elazar M., Cheong K.H., Liu P., Greenberg H.B., Rice C.M., Glenn J.S. 2003; Amphipathic helix-dependent localization of NS5A mediates hepatitis C virus RNA replication. J Virol 77:6055–6061 [CrossRef][PubMed]
    [Google Scholar]
  8. Foster T.L., Belyaeva T., Stonehouse N.J., Pearson A.R., Harris M. 2010; All three domains of the hepatitis C virus nonstructural NS5A protein contribute to RNA binding. J Virol 84:9267–9277 [CrossRef][PubMed]
    [Google Scholar]
  9. Grøvdal L.M., Stang E., Sorkin A., Madshus I.H. 2004; Direct interaction of Cbl with pTyr 1045 of the EGF receptor (EGFR) is required to sort the EGFR to lysosomes for degradation. Exp Cell Res 300:388–395 [CrossRef][PubMed]
    [Google Scholar]
  10. Haglund K., Shimokawa N., Szymkiewicz I., Dikic I. 2002; Cbl-directed monoubiquitination of CIN85 is involved in regulation of ligand-induced degradation of EGF receptors. Proc Natl Acad Sci U S A 99:12191–12196 [CrossRef][PubMed]
    [Google Scholar]
  11. Huang F., Goh L.K., Sorkin A. 2007; EGF receptor ubiquitination is not necessary for its internalization. Proc Natl Acad Sci U S A 104:16904–16909 [CrossRef][PubMed]
    [Google Scholar]
  12. Huang L., Hwang J., Sharma S.D., Hargittai M.R., Chen Y., Arnold J.J., Raney K.D., Cameron C.E. 2005; Hepatitis C virus nonstructural protein 5A (NS5A) is an RNA-binding protein. J Biol Chem 280:36417–36428 [CrossRef][PubMed]
    [Google Scholar]
  13. Huang F., Zeng X., Kim W., Balasubramani M., Fortian A., Gygi S.P., Yates N.A., Sorkin A. 2013; Lysine 63-linked polyubiquitination is required for EGF receptor degradation. Proc Natl Acad Sci U S A 110:15722–15727 [CrossRef][PubMed]
    [Google Scholar]
  14. Hughes M., Griffin S., Harris M. 2009a; Domain III of NS5A contributes to both RNA replication and assembly of hepatitis C virus particles. J Gen Virol 90:1329–1334 [CrossRef][PubMed]
    [Google Scholar]
  15. Hughes M., Gretton S., Shelton H., Brown D.D., McCormick C.J., Angus A.G., Patel A.H., Griffin S., Harris M. 2009b; A conserved proline between domains II and III of hepatitis C virus NS5A influences both RNA replication and virus assembly. J Virol 83:10788–10796 [CrossRef][PubMed]
    [Google Scholar]
  16. Kärkkäinen S., Hiipakka M., Wang J.H., Kleino I., Vähä-Jaakkola M., Renkema G.H., Liss M., Wagner R., Saksela K. 2006; Identification of preferred protein interactions by phage-display of the human Src homology-3 proteome. EMBO Rep 7:186–191 [CrossRef][PubMed]
    [Google Scholar]
  17. Kato T., Date T., Miyamoto M., Furusaka A., Tokushige K., Mizokami M., Wakita T. 2003; Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon. Gastroenterology 125:1808–1817 [CrossRef][PubMed]
    [Google Scholar]
  18. Kirsch K.H., Georgescu M.M., Shishido T., Langdon W.Y., Birge R.B., Hanafusa H. 2001; The adapter type protein CMS/CD2AP binds to the proto-oncogenic protein c-Cbl through a tyrosine phosphorylation-regulated Src homology 3 domain interaction. J Biol Chem 276:4957–4963 [CrossRef][PubMed]
    [Google Scholar]
  19. Koike K. 2014; The oncogenic role of hepatitis C virus. Recent Results Cancer Res 193:97–111 [CrossRef][PubMed]
    [Google Scholar]
  20. Lambert S.M., Langley D.R., Garnett J.A., Angell R., Hedgethorne K., Meanwell N.A., Matthews S.J. 2014; The crystal structure of NS5A domain 1 from genotype 1a reveals new clues to the mechanism of action for dimeric HCV inhibitors. Protein Sci 23:723–734 [CrossRef][PubMed]
    [Google Scholar]
  21. Love R.A., Brodsky O., Hickey M.J., Wells P.A., Cronin C.N. 2009; Crystal structure of a novel dimeric form of NS5A domain I protein from hepatitis C virus. J Virol 83:4395–4403 [CrossRef][PubMed]
    [Google Scholar]
  22. Lupberger J., Zeisel M.B., Xiao F., Thumann C., Fofana I., Zona L., Davis C., Mee C.J., Turek M., other authors. 2011; EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy. Nat Med 17:589–595 [CrossRef][PubMed]
    [Google Scholar]
  23. Lupberger J., Duong F.H., Fofana I., Zona L., Xiao F., Thumann C., Durand S.C., Pessaux P., Zeisel M.B., other authors. 2013; Epidermal growth factor receptor signaling impairs the antiviral activity of interferon-alpha. Hepatology 58:1225–1235 [CrossRef][PubMed]
    [Google Scholar]
  24. Macdonald A., Crowder K., Street A., McCormick C., Saksela K., Harris M. 2003; The hepatitis C virus non-structural NS5A protein inhibits activating protein-1 (AP1) function by perturbing Ras-ERK pathway signalling. J Biol Chem 278:17775–17784 [CrossRef][PubMed]
    [Google Scholar]
  25. Macdonald A., Crowder K., Street A., McCormick C., Harris M. 2004; The hepatitis C virus NS5A protein binds to members of the Src family of tyrosine kinases and regulates kinase activity. J Gen Virol 85:721–729 [CrossRef][PubMed]
    [Google Scholar]
  26. Macdonald A., Chan J.K., Harris M. 2005a; Perturbation of epidermal growth factor receptor complex formation and Ras signalling in cells harbouring the hepatitis C virus subgenomic replicon. J Gen Virol 86:1027–1033 [CrossRef][PubMed]
    [Google Scholar]
  27. Macdonald A., Mazaleyrat S., McCormick C., Street A., Burgoyne N.J., Jackson R.M., Cazeaux V., Shelton H., Saksela K., Harris M. 2005b; Further studies on hepatitis C virus NS5A-SH3 domain interactions: identification of residues critical for binding and implications for viral RNA replication and modulation of cell signalling. J Gen Virol 86:1035–1044 [CrossRef][PubMed]
    [Google Scholar]
  28. Mankouri J., Griffin S., Harris M. 2008; The hepatitis C virus non-structural protein NS5A alters the trafficking profile of the epidermal growth factor receptor. Traffic 9:1497–1509 [CrossRef][PubMed]
    [Google Scholar]
  29. Mayer B.J. 2001; SH3 domains: complexity in moderation. J Cell Sci 114:1253–1263[PubMed]
    [Google Scholar]
  30. McCormick C.J., Maucourant S., Griffin S., Rowlands D.J., Harris M. 2006; Tagging of NS5A expressed from a functional hepatitis C virus replicon. J Gen Virol 87:635–640 [CrossRef][PubMed]
    [Google Scholar]
  31. Nanda S.K., Herion D., Liang T.J. 2006; Src homology 3 domain of hepatitis C virus NS5A protein interacts with Bin1 and is important for apoptosis and infectivity. Gastroenterology 130:794–809 [CrossRef][PubMed]
    [Google Scholar]
  32. Neuvonen M., Kazlauskas A., Martikainen M., Hinkkanen A., Ahola T., Saksela K. 2011; SH3 domain-mediated recruitment of host cell amphiphysins by alphavirus nsP3 promotes viral RNA replication. PLoS Pathog 7:e1002383 [CrossRef][PubMed]
    [Google Scholar]
  33. Peschard P., Park M. 2003; Escape from Cbl-mediated downregulation: a recurrent theme for oncogenic deregulation of receptor tyrosine kinases. Cancer Cell 3:519–523 [CrossRef][PubMed]
    [Google Scholar]
  34. Ross-Thriepland D., Harris M. 2014; Insights into the complexity and functionality of hepatitis C virus NS5A phosphorylation. J Virol 88:1421–1432 [CrossRef][PubMed]
    [Google Scholar]
  35. Ross-Thriepland D., Harris M. 2015; Hepatitis C virus NS5A: enigmatic but still promiscuous 10 years on!. J Gen Virol 96:727–738 [CrossRef][PubMed]
    [Google Scholar]
  36. Ross-Thriepland D., Amako Y., Harris M. 2013; The C terminus of NS5A domain II is a key determinant of hepatitis C virus genome replication, but is not required for virion assembly and release. J Gen Virol 94:1009–1018 [CrossRef][PubMed]
    [Google Scholar]
  37. Scheel T.K., Rice C.M. 2013; Understanding the hepatitis C virus life cycle paves the way for highly effective therapies. Nat Med 19:837–849 [CrossRef][PubMed]
    [Google Scholar]
  38. Shelton H., Harris M. 2008; Hepatitis C virus NS5A protein binds the SH3 domain of the Fyn tyrosine kinase with high affinity: mutagenic analysis of residues within the SH3 domain that contribute to the interaction. Virol J 5:24 [CrossRef][PubMed]
    [Google Scholar]
  39. Soubeyran P., Kowanetz K., Szymkiewicz I., Langdon W.Y., Dikic I. 2002; Cbl-CIN85-endophilin complex mediates ligand-induced downregulation of EGF receptors. Nature 416:183–187 [CrossRef][PubMed]
    [Google Scholar]
  40. Stang E., Johannessen L.E., Knardal S.L., Madshus I.H. 2000; Polyubiquitination of the epidermal growth factor receptor occurs at the plasma membrane upon ligand-induced activation. J Biol Chem 275:13940–13947 [CrossRef][PubMed]
    [Google Scholar]
  41. Szymkiewicz I., Kowanetz K., Soubeyran P., Dinarina A., Lipkowitz S., Dikic I. 2002; CIN85 participates in Cbl-b-mediated down-regulation of receptor tyrosine kinases. J Biol Chem 277:39666–39672 [CrossRef][PubMed]
    [Google Scholar]
  42. Tan S.L., Nakao H., He Y., Vijaysri S., Neddermann P., Jacobs B.L., Mayer B.J., Katze M.G. 1999; NS5A, a nonstructural protein of hepatitis C virus, binds growth factor receptor-bound protein 2 adaptor protein in a Src homology 3 domain/ligand-dependent manner and perturbs mitogenic signaling. Proc Natl Acad Sci U S A 96:5533–5538 [CrossRef][PubMed]
    [Google Scholar]
  43. Tellinghuisen T.L., Marcotrigiano J., Gorbalenya A.E., Rice C.M. 2004; The NS5A protein of hepatitis C virus is a zinc metalloprotein. J Biol Chem 279:48576–48587 [CrossRef][PubMed]
    [Google Scholar]
  44. Tellinghuisen T.L., Marcotrigiano J., Rice C.M. 2005; Structure of the zinc-binding domain of an essential component of the hepatitis C virus replicase. Nature 435:374–379 [CrossRef][PubMed]
    [Google Scholar]
  45. Zheng K., Kitazato K., Wang Y. 2014; Viruses exploit the function of epidermal growth factor receptor. Rev Med Virol 24:274–286 [CrossRef][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.000145
Loading
/content/journal/jgv/10.1099/vir.0.000145
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error